{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:27:03Z","timestamp":1764905223779,"version":"3.46.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,4]]},"DOI":"10.7759\/cureus.98476","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T02:20:36Z","timestamp":1764901236000},"source":"Crossref","is-referenced-by-count":0,"title":["Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective"],"prefix":"10.7759","author":[{"given":"Mohamad","family":"Mosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refat","family":"Jayyusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaila","family":"Saaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moin","family":"Makrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Saadaldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112647","article-title":"An update on the pathology and molecular features of Hodgkin lymphoma","volume":"14","author":"Satou A","year":"2022","unstructured":"Satou A, Takahara T, Nakamura S. An update on the pathology and molecular features of Hodgkin lymphoma. Cancers (Basel). 2022, 14:2647. 10.3390\/cancers14112647","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-212117","article-title":"Global incidence, mortality and risk factors of Hodgkins and non-Hodgkins lymphoma 1990-2021: a global health data study","volume":"144","author":"Kundu R","year":"2024","unstructured":"Kundu R, Kal N, Singh A, Jagadeesh D. Global incidence, mortality and risk factors of Hodgkins and non-Hodgkins lymphoma 1990-2021: a global health data study. Blood. 2024, 144:6360. 10.1182\/blood-2024-212117","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27470","article-title":"Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management","volume":"99","author":"Ansell SM","year":"2024","unstructured":"Ansell SM. Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024, 99:2367-78. 10.1002\/ajh.27470","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2014.053","article-title":"Prognostic factors in hodgkin lymphoma","volume":"6","author":"Cuccaro A","year":"2014","unstructured":"Cuccaro A, Bartolomei F, Cupelli E, Galli E, Giachelia M, Hohaus S. Prognostic factors in hodgkin lymphoma. Mediterr J Hematol Infect Dis. 2014, 6:2014053. 10.4084\/MJHID.2014.053","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref5","article-title":"Physiology and genetics of procalcitonin","volume":"49","author":"Maruna P","year":"2000","unstructured":"Maruna P, Nedeln\u00edkov\u00e1 K, G\u00fcrlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000, 49:57-61.","journal-title":"Physiol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151143","article-title":"Classical Hodgkin lymphoma; real-world observations from physicians, patients, and caregivers on the disease and its treatment (CONNECT): observations of Physicians on treatment and interim PET-adapted regimens","volume":"138","author":"Flora DR","year":"2021","unstructured":"Flora DR, Parsons SK, Liu N, et al.. Classical Hodgkin lymphoma; real-world observations from physicians, patients, and caregivers on the disease and its treatment (CONNECT): observations of Physicians on treatment and interim PET-adapted regimens. Blood. 2021, 138:1390. 10.1182\/blood-2021-151143","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang HW","year":"2019","unstructured":"Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES. Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol. 2019, 184:45-59. 10.1111\/bjh.15614","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2397072","article-title":"Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse","volume":"65","author":"Braun AP","year":"2024","unstructured":"Braun AP, Herrera A. Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse. Leuk Lymphoma. 2024, 65:2088-95. 10.1080\/10428194.2024.2397072","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.1331","article-title":"Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Casasnovas RO","year":"2007","unstructured":"Casasnovas RO, Mounier N, Brice P, et al.. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2007, 25:1732-40. 10.1200\/JCO.2006.08.1331","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2021.0617","article-title":"Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged \u226450 years","volume":"72","author":"Rafiq M","year":"2022","unstructured":"Rafiq M, Abel G, Renzi C, Lyratzopoulos G. Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged \u226450 years. Br J Gen Pract. 2022, 72:546-55. 10.3399\/BJGP.2021.0617","journal-title":"Br J Gen Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101331","article-title":"Serum procalcitonin levels in newly diagnosed Hodgkin lymphoma: correlation with other inflammatory biomarkers","volume":"58","author":"Piperidou A","year":"2022","unstructured":"Piperidou A, Zografos E, Vassilakopoulos TJ, et al.. Serum procalcitonin levels in newly diagnosed Hodgkin lymphoma: correlation with other inflammatory biomarkers. Medicina (Kaunas). 2022, 58:1331. 10.3390\/medicina58101331","journal-title":"Medicina (Kaunas)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/435955-procalcitonin-as-a-potential-prognostic-marker-in-advanced-hodgkin-lymphoma-a-case-based-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T02:20:40Z","timestamp":1764901240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/435955-procalcitonin-as-a-potential-prognostic-marker-in-advanced-hodgkin-lymphoma-a-case-based-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.98476","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}